By leveraging the productive capabilities of microalgae, Solazyme creates oils that mirror or enhance the chemical composition of conventional oils used today. Unlike other approaches that use direct photosynthesis to grow algae, Solazyme uses standard industrial fermentation equipment that harnesses the prolific oil-producing ability of microalgae, allowing the company to produce oils in a matter of days. Solazyme's technology platform is feedstock flexible and can utilize a wide variety of plant-based sugars. The oils the company produces provide compelling solutions to increasingly complex issues of fuel scarcity, energy security and environmental impact all while fitting into pre-existing infrastructure.
Solazyme trades on NASDAQ under the ticker symbol SZYM.
Solazyme was incorporated in 2003.
225 Gateway Blvd.
South San Francisco, CA 94408
Main Phone: (650) 780- 4777
Solazyme's fiscal year ends December 31.
Morgan Stanley & Co. Incorporated, Goldman Sachs & Co. acted as book-running managers for the offering and Jefferies, Pacific Crest Securities LLC and Lazard Capital Markets LLC acted as co-managers for the offering.
A copy of the final prospectus related to the IPO may be obtained from Morgan Stanley at 1-866-718-1649 or Goldman Sachs at 1-866-471-2526.
Solazyme does not currently have a direct stock purchase plan.
Visit the Events section of our website for information on upcoming calls. Information will be posted as available.
No, Solazyme does not intend to pay cash dividends on its capital stock in the foreseeable future.
Solazyme is closed to the public and does not offer tours.
I am working on a school project. Can I interview someone from Solazyme or will you please send me materials that I can use as part of a presentation?
We receive a large number of requests for information in connection with student projects, and unfortunately are not able to respond to each one individually. This web site, however, contains answers to many of the most commonly asked questions about Solazyme, our technology, and the work we are doing.
Additional information may be obtained by reading our SEC filings.
Now that the IPO is completed, please contact your broker or financial advisor for advice on how to handle this transaction.
If you are a stockholder of record, please contact Solazyme' s transfer agent at:
250 Royall Street, Canton, MA 02021
Brainerd Communicators, Inc.
Please submit your question using the form below. * Required fields